CADTH has received notice of a pending submission from Cubist for Sivextro (tedizolid phosphate) for patients with an acute bacterial skin and skin structure infection. For information about the patient input process or for additional instructions, please see the Patient Input page of the CADTH website. Note that only patient groups may submit input.

For more details, go to: http://www.cadth.ca/en/products/cdr/patient-group-input-form/395